Scholarly Index
Thomas A. Wynn
Pfizer (United States); 73,878 total citations; 292 total publications; best world rank #10
Pfizer (United States)
73,878Total citations
292Total publications
113H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Parasitology | Lifetime | 33 | US 23 | 99.61 |
| Immunology | Lifetime | 340 | US 175 | 99.16 |
| Parasites and Host Interactions | Lifetime | 10 | US 6 | 99.83 |
| IL-33, ST2, and ILC Pathways | Lifetime | 22 | US 13 | 99.65 |
| Research on Leishmaniasis Studies | Lifetime | 42 | US 17 | 99.44 |
| Immune cells in cancer | Lifetime | 90 | US 39 | 99.35 |
| Immune Cell Function and Interaction | Lifetime | 499 | US 277 | 99.34 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 178 | US 90 | 98.88 |
| Asthma and respiratory diseases | Lifetime | 763 | US 276 | 98.33 |
| Macrophage Migration Inhibitory Factor | Lifetime | 77 | US 44 | 96.73 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 611 | US 268 | 96.98 |
| Parasite Biology and Host Interactions | Lifetime | 775 | US 178 | 96.05 |
| Helminth infection and control | Lifetime | 668 | US 164 | 95.13 |
| Occupational and environmental lung diseases | Lifetime | 827 | US 326 | 93.07 |